Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction

Hepatic gluconeogenesis is absolutely required for survival during prolonged fasting or starvation, but is inappropriately activated in diabetes mellitus. Glucocorticoids and glucagon have strong gluconeogenic actions on the liver. In contrast, insulin suppresses hepatic gluconeogenesis. Two components known to have important physiological roles in this process are the forkhead transcription factor FOXO1 (also known as FKHR) and peroxisome proliferative activated receptor-γ co-activator 1 (PGC-1α; also known as PPARGC1), a transcriptional co-activator; whether and how these factors collaborate has not been clear. Using wild-type and mutant alleles of FOXO1, here we show that PGC-1α binds and co-activates FOXO1 in a manner inhibited by Akt-mediated phosphorylation. Furthermore, FOXO1 function is required for the robust activation of gluconeogenic gene expression in hepatic cells and in mouse liver by PGC-1α. Insulin suppresses gluconeogenesis stimulated by PGC-1α but co-expression of a mutant allele of FOXO1 insensitive to insulin completely reverses this suppression in hepatocytes or transgenic mice. We conclude that FOXO1 and PGC-1α interact in the execution of a programme of powerful, insulin-regulated gluconeogenesis.

[1]  Neil J. McKenna,et al.  Combinatorial Control of Gene Expression by Nuclear Receptors and Coregulators , 2002, Cell.

[2]  P. Cohen,et al.  Phosphorylation of the Transcription Factor Forkhead Family Member FKHR by Protein Kinase B* , 1999, The Journal of Biological Chemistry.

[3]  M. Cole,et al.  Nuclear receptor function requires a TFTC-type histone acetyl transferase complex. , 2002, Molecular cell.

[4]  R. O’Brien,et al.  Regulation of Phosphoenolpyruvate Carboxykinase and Insulin-like Growth Factor-binding Protein-1 Gene Expression by Insulin , 2000, The Journal of Biological Chemistry.

[5]  D. Accili,et al.  The forkhead transcription factor Foxo1 regulates adipocyte differentiation. , 2003, Developmental cell.

[6]  M. Greenberg,et al.  Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor , 1999, Cell.

[7]  C. Bradfield,et al.  Ah receptor signaling pathways. , 1996, Annual review of cell and developmental biology.

[8]  K. Umesono,et al.  The nuclear receptor superfamily: The second decade , 1995, Cell.

[9]  S. Kato,et al.  A subfamily of RNA-binding DEAD-box proteins acts as an estrogen receptor alpha coactivator through the N-terminal activation domain (AF-1) with an RNA coactivator, SRA. , 2001, The EMBO journal.

[10]  P. Puigserver,et al.  A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis , 1998, Cell.

[11]  Y. Fujii‐Kuriyama,et al.  Ah receptor: a novel ligand-activated transcription factor. , 1994, Experimental and clinical immunogenetics.

[12]  T. Kitamoto,et al.  p300 Mediates Functional Synergism between AF-1 and AF-2 of Estrogen Receptor α and β by Interacting Directly with the N-terminal A/B Domains* , 2000, The Journal of Biological Chemistry.

[13]  A. Gibbons.  Dioxin tied to endometriosis. , 1993, Science.

[14]  D. Accili,et al.  Regulation of insulin action and pancreatic β-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1 , 2002, Nature Genetics.

[15]  T. Thomas,et al.  Transcriptional suppression of estrogen receptor gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) , 1998, The Journal of Steroid Biochemistry and Molecular Biology.

[16]  D. Azzout-Marniche,et al.  Adenovirus-mediated overexpression of sterol regulatory element binding protein-1c mimics insulin effects on hepatic gene expression and glucose homeostasis in diabetic mice. , 2001, Diabetes.

[17]  Y. Fujii‐Kuriyama,et al.  Identification of a novel mechanism of regulation of Ah (dioxin) receptor function. , 1999, Genes & development.

[18]  Guillaume Adelmant,et al.  Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1 , 2001, Nature.

[19]  M. Mueller,et al.  Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors alpha and beta. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[20]  D. Nebert,et al.  Dioxin induces expression of c-fos and c-jun proto-oncogenes and a large increase in transcription factor AP-1. , 1992, DNA and cell biology.

[21]  C. Rogler,et al.  Hepatic Overexpression of Insulin-like Growth Factor-II in Adulthood Increases Basal and Insulin-stimulated Glucose Disposal in Conscious Mice (*) , 1996, The Journal of Biological Chemistry.

[22]  D. Accili,et al.  Insulin Stimulates Phosphorylation of the Forkhead Transcription Factor FKHR on Serine 253 through a Wortmannin-sensitive Pathway* , 1999, The Journal of Biological Chemistry.

[23]  D. Yee,et al.  FKHR binds the insulin response element in the insulin-like growth factor binding protein-1 promoter. , 1999, Endocrinology.

[24]  Marc Montminy,et al.  CREB regulates hepatic gluconeogenesis through the coactivator PGC-1 , 2001, Nature.

[25]  Daniel Metzger,et al.  Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase , 1995, Science.

[26]  P. Chambon,et al.  Effect of single and compound knockouts of estrogen receptors α (ERα) and β (ERβ) on mouse reproductive phenotypes , 2000 .

[27]  Thorsten Heinzel,et al.  A CBP Integrator Complex Mediates Transcriptional Activation and AP-1 Inhibition by Nuclear Receptors , 1996, Cell.

[28]  A. Weisz,et al.  Identification of an estrogen response element upstream of the human c-fos gene that binds the estrogen receptor and the AP-1 transcription factor. , 1990, Nucleic acids research.

[29]  R. Unger,et al.  Glucagon physiology and pathophysiology in the light of new advances , 1985, Diabetologia.

[30]  D. Granner,et al.  Insulin Regulates Expression of Metabolic Genes through Divergent Signaling Pathways , 1999, Journal of basic and clinical physiology and pharmacology.

[31]  Anita Nur Mayani,et al.  Dioxin concentrations in women with endometriosis. , 1997, Human reproduction.

[32]  G. Darlington,et al.  C/EBPα: a critical regulator of genes governing integrative metabolic processes , 1995 .

[33]  O. Hankinson,et al.  Recruitment of the NCoA/SRC-1/p160 Family of Transcriptional Coactivators by the Aryl Hydrocarbon Receptor/Aryl Hydrocarbon Receptor Nuclear Translocator Complex , 2002, Molecular and Cellular Biology.

[34]  G. Darlington,et al.  C/EBP alpha: a critical regulator of genes governing integrative metabolic processes. , 1995, Current opinion in genetics & development.

[35]  N. Webster,et al.  The human estrogen receptor has two independent nonacidic transcriptional activation functions , 1989, Cell.

[36]  L. Freedman.  Increasing the Complexity of Coactivation in Nuclear Receptor Signaling , 1999, Cell.

[37]  T. Klonisch,et al.  Arylhydrocarbon receptor expression in the human endometrium. , 1999, Fertility and sterility.

[38]  A. Fornace,et al.  The involvement of aryl hydrocarbon receptor in the activation of transforming growth factor-beta and apoptosis. , 1998, Molecular pharmacology.

[39]  R. Walther,et al.  Regulation of glucose-6-phosphatase gene expression by protein kinase Balpha and the forkhead transcription factor FKHR. Evidence for insulin response unit-dependent and -independent effects of insulin on promoter activity. , 2000, The Journal of biological chemistry.

[40]  Jun Wang,et al.  Prenatal TCDD and predisposition to mammary cancer in the rat. , 1998, Carcinogenesis.

[41]  Guillaume Adelmant,et al.  Activation of PPARγ coactivator-1 through transcription factor docking , 1999 .

[42]  V. Poli,et al.  The Transcription Factor CCAAT/Enhancer-binding Protein β Regulates Gluconeogenesis and Phosphoenolpyruvate Carboxykinase (GTP) Gene Transcription during Diabetes* , 1999, The Journal of Biological Chemistry.

[43]  Kenji Nakamura,et al.  Loss of teratogenic response to 2,3,7,8‐tetrachlorodibenzo‐p‐dioxin (TCDD) in mice lacking the Ah (dioxin) receptor , 1997, Genes to cells : devoted to molecular & cellular mechanisms.

[44]  R. Hanson,et al.  Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression. , 1997, Annual review of biochemistry.

[45]  A. Fukamizu,et al.  Regulation of PGC-1 promoter activity by protein kinase B and the forkhead transcription factor FKHR. , 2003, Diabetes.

[46]  G. Lucier,et al.  Ovarian tumors in rats induced by chronic 2,3,7,8-tetrachlorodibenzo-p-dioxin treatment. , 2000, Cancer research.

[47]  D. Accili,et al.  The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression. , 2001, The Journal of clinical investigation.

[48]  A. Kralli,et al.  A Tissue-Specific Coactivator of Steroid Receptors, Identified in a Functional Genetic Screen , 2000, Molecular and Cellular Biology.